One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Chile Respiratory Devices Market

[ 英語タイトル ] Chile Respiratory Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0088894
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 80
Category : Healthcare and Pharmaceuticals
Study Area : Chile
Report format : PDF
Sales price option (consumption tax not included)
Single User USD3250 / Question Form
5 User USD3750 / Question Form
Enterprise User USD6500 / Question Form
 - Dragerwerk AG
- Fisher & Paykel Healthcare Ltd
- GE Healthcare
- GlaxoSmithKline PLC
- Invacare Corporation
- Koninklijke Philips NV
- Medtronic PLC

[Report Description]

The rising burden of respiratory disorders such as chronic obstructive pulmonary disease patients (COPD), TB, asthma, etc. remains the major driver of the industry. Chronic respiratory diseases are chronic diseases that affect the airways and other parts of the lungs. Respiratory symptoms are among the major causes of consultation with doctors and physicians in primary health care centers. Some of the major preventable chronic respiratory disorders are asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, sleep apnea, and tuberculosis (principally, multi-drug resistant tuberculosis). According to Organisation for Economic Co-operation and Development (OECD), in 2017, Chile reported around 32.4 hospital discharges per 100,0000 inhabitants due to asthma, up from 29.5 a year before. Thus, owing to these factors, the demand for respiratory devices are expected to grow substantially, over the forecast period.

Key Market Trends

Sleep Test Device Segment is Expected to Show Better Growth Over the Forecast Period

Sleep test devices are expected to register an exponential growth, due to the increasing availability of portable instruments, such as CleveMed’s SleepView [home sleep monitor], which integrates several studies (oximetry, position, and cardiovascular and respiratory studies). Also, some of the sleep testing devices can be rented, which is resulting in the market expansion and this will further fuel their adoption. Furthermore, with the rising burden of respiratory diseases, such as Asthma and COPD, the demand for respiratory devices is also expected to rise, which will propel the market growth, over the forecast period.

Competitive Landscape

The majority of the respiratory devices is being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market, which has helped the market grow.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Respiratory Disorders
4.2.2 Increasing Geriatric Population
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Type
5.1.1 By Diagnostic and Monitoring Devices Spirometers Sleep Test Devices Peak Flow Meters Pulse Oximeters Other Diagnostic and Monitoring Devices
5.1.2 By Therapeutic Devices CPAP Devices BiPAP Devices Nebulizers Oxygen Concentrators Ventilators Inhalers Other Therapeutic Devices
5.1.3 By Disposables Masks Breathing Circuits Other Disposables

6.1 Company Profiles
6.1.1 Dragerwerk AG
6.1.2 Fisher & Paykel Healthcare Ltd
6.1.3 GE Healthcare
6.1.4 GlaxoSmithKline PLC
6.1.5 Invacare Corporation
6.1.6 Koninklijke Philips NV
6.1.7 Medtronic PLC




Recommended reports